Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 24, 2021

SELL
$9.38 - $13.63 $68,239 - $99,158
-7,275 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$7.78 - $12.13 $37,149 - $57,920
4,775 Added 191.0%
7,275 $75,000
Q3 2020

Nov 16, 2020

BUY
$9.5 - $11.14 $23,750 - $27,850
2,500 New
2,500 $25,000
Q4 2018

Feb 15, 2019

SELL
$20.07 - $46.7 $2,007 - $4,670
-100 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$41.2 - $59.85 $4,120 - $5,985
100 New
100 $5,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $138M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.